Prime Medicine
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $186,639,000.

Profit Margin

Prime Medicine, Inc. (NASDAQ:PRME): Profit margin
2019 0 -2.52M
2020 5.21M -3.41M -65.45%
2021 0 -165.36M
2022 5.21M -121.82M -2338.21%
2023 0 -198.13M

PRME Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
05.21M05.21M0
Cost of revenue
147.90M12.01M4.86M02.76M
Gross profit
-147.90M-6.80M-4.86M0-2.76M
Operating exp.
Research and development
147.90M86.72M70.55M2.98M920K
Selling and marketing
-4.65M0001.24M
Total operating expenses
186.63M116.54M84.47M6.14M2.17M
Operating income
-191.29M-116.54M-84.47M-932K-2.17M
Other income (expenses), net
-7.12M-6.22M-81.37M-611K-353K
Income before tax
-198.41M-122.76M-165.85M-1.54M-2.52M
Income tax expense
-279K-948K-486K1.86M4K
Net income
-198.13M-121.82M-165.36M-3.41M-2.52M
Earnings per share
Basic EPS
-2.18-1.25-1.73-0.07-0.02
Diluted EPS
-2.18-1.25-1.73-0.07-0.02
Data sourceData source